Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Khalid M AlNaamaniDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.ORCID 0000-0002-2892-266X
Wafa Al-TamtamiDepartment of Medical Laboratory, Division of Medical Microbiology, The Medical City for Military and Security Services, Muscat 111, Oman.
Mohamed El-KassasEndemic Medicine Department, Faculty of Medicine, Helwan University, Cairo 11795, Egypt.ORCID 0000-0002-3396-6894
Heba OmarDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.ORCID 0000-0002-9707-1141
Abdullah AlKalbaniDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.
Bola R KamathDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.
Halima AlshuailiDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.ORCID 0009-0008-6168-5601
Amal AnwarDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.ORCID 0000-0003-4300-5920
Alya AlKalbaniDepartment of Nursing, The Medical City for Military and Security Services, Muscat 111, Oman.
Hajer AlShukailiDepartment of Medical Laboratory, Division of Medical Microbiology, The Medical City for Military and Security Services, Muscat 111, Oman.
Malak AlSawafiDepartment of Medicine, Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat 111, Oman.
Muneera AlShukailiDepartment of Nursing, The Medical City for Military and Security Services, Muscat 111, Oman.
Siham AlSinaniDepartment of Child Health, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
fibrosishepatitis B virushepatitis D virusOmanrisk factorsseroprevalence
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Omani Patients with Chronic Hepatitis B: A Multicenter Cross-Sectional Study. · full record | OpenQuestion